Assessment of Saccharomyces boulardii effect on rats Staphylococcus aureus induced skin infection: an in-vivo study
Abstract
A concerning global health issue is the growing incidence of antibiotic resistance in skin and soft tissue
infection. This study aimed to assess the healing potential of topically applied Saccharomyces boulardii on excisional skin
wound infected with Staphylococcus aureus using a rat model. The wounded animals were divided into three groups;
group 1: uninfected untreated, group 2: infected untreated and group 3: infected S. boulardii-treated. Treatment
commenced 2 days post infection. Parameters studied were wound microbial load, rate of wound contraction, serum
C-reactive protein (CRP) level and rat β-defensin 1 (RBD-1) gene expression. Staphylococcal bacterial load decline was
significantly (p < 0.05) higher in group 3 when compared to group 2 at day 5, 6 and 7 accompanied by a growing of S.
boulardii load on the animals of group 3. A complete wound closure (100%) was monitored in study group 3 at day 7 in
comparison to the control groups, where partial healing was achieved (67.10 and 91.74% in group 1 and 2 respectively).
No significant difference of CRP level among the three groups was encountered indicating no influence of S. boulardii
on this protein. RBD-1 gene expression in group 3 was found higher than the two control groups (p < 0.05 and < 0.01 in
comparison to group 1 and group 2 respectively). Topical application of S. boulardii was shown able to enhance wound
healing and competitively exclude the infecting pathogen. The increased antimicrobial peptide gene expression in S.
boulardii treated group might contribute to its healing potential.
Keywords
Bacterial load C-reactive protein defensin gene expression Saccharomyces boulardii skin wound Staphylococcus aureus
References
- [1] Theoret CL. The pathophysiology of wound repair. Vet Clin North Am Equine Pract. 2005; 21(1): 1-13. [CrossRef]
- [2] Hersh AL, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch. Intern. Med. 2008; 168: 1585–1591. doi: 10.1001/archinte.168.14. 1585. [CrossRef]
- [3] Miller LG, Eisenberg DF, Liu H, Chang CL, Wang Y, Luthra R, Wallace A, Fang C, Singer J, Suaya JA. Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005–2010. BMC Infect Dis. 2015; 15(1): 1-8. [CrossRef]
- [4] Kaye KS, Petty LA, Shorr AF, Zilberberg MD. Current epidemiology, etiology, and burden of acute skin infections in the United States. Clin Infect Dis. 2019; 68(Supplement_3): S193-199. [CrossRef]
- [5] Stashak TS, Theoret CL. Wound repair: problems in the horse and innovative solutions. In: Stashak T, Theoret CL. (Eds). Equine wound management. 2. Ames: Wiley-Blackwell, 2008, pp. 47–68.
- [6] Gordillo GM, Sen CK. Revisiting the essential role of oxygen in wound healing. Am J Surg. 2003; 186: 259–263. [CrossRef]
- [7] Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev. 2001; 14(2): 244–269. [CrossRef]
- [8] Lowy FD. Staphylococcus aureus infections. N. Engl. J. Med. 1998; 339: 520–532. [CrossRef]
- [9] Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015; 28(3): 603-661. [CrossRef]
- [10] Clinton A, Carter T. Chronic wound biofilms: pathogenesis and potential therapies. Lab Med. 2015; 46: 277–284. [CrossRef]
- [11] Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014; 59(2): e10-52. [CrossRef]
- [12] Ramakrishnan K, Salinas RC, Agudelo NI. Skin and soft tissue infections. Am. Fam. Physician. 2015; 92: 474–483.
- [13] Hashim ZA. Evaluation of bacterial contents, package labelling and antimicrobial activity of some commercial probiotic products available in local market. J Res Pharm. 2022; 26(3): 502-509. [CrossRef]
- [14] Partlow J, Blikslager A, Matthews C, Law M, Daniels J, Baker R, Labens R. Effect of topically applied Saccharomyces boulardii on the healing of acute porcine wounds: a preliminary study. BMC Res Notes. 2016; 9(1): 1-7. [CrossRef]
- [15] Buts JP. Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives. Digest Dis Sci. 2009; 54(1): 15-18. [CrossRef]
- [16] Pothoulakis C. Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii. Aliment Pharmacol Ther. 2009; 30(8): 826–833. [CrossRef]
- [17] Hatoum R, Labrie S, Fliss I. Antimicrobial and probiotic properties of yeasts: from fundamental to novel applications. Front Microbiol. 2012; 3: 421. [CrossRef]
- [18] Viljoen BC. Yeast ecological interactions. Yeast'Yeast, Yeast'Bacteria, Yeast'Fungi interactions and yeasts as biocontrol agents. In: Yeasts in food and beverages. Springer, Berlin, Heidelberg, 2006, pp. 83-110. [CrossRef]
- [19] Babineau TJ, Hackford A, Kenler A, Bistrian B, Forse RA, Fairchild PG, Heard S, Keroack M, Caushaj P, Benotti P. A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGGglucan) in high-risk surgical patients. Arch Surg. 1994; 129(11): 1204-1210. [CrossRef]
- [20] Zahedi F, Nasrabadi HM, Ebrahimi TM, Shabani M, Aboutalebi H. The effect of Lactobacillus brevis isolated from Iranian traditional cheese on cutaneous wound healing in rats. J Cell Anim Biol. 2011; 5(12): 265–270. [CrossRef]
- [21] Nasrabadi HM, Ebrahimi TM, Banadaki DS, Kajousangi TM, Zahedi F. Study of cutaneous wound healing in rats treated with Lactobacillus plantarum on days 1, 3, 7, 14 and 21. Afr J Pharm Pharmacol. 2011; 5(21): 2395–2401.
- [22] Chieosilapatham P, Ogawa H, Niyonsaba F. Current insights into the role of human β-defensins in atopic dermatitis. Clin Exp Immunol. 2017; 190(2): 155-166. [CrossRef]
- [23] Yang L, Tian ZB, Yu YN, Zhang CP, Li XY, Mao T, Jing X, Zhao WJ, Ding XL, Yang RM, Zhang SQ. Saccharomyces boulardii administration can inhibit the formation of gastric lymphoid follicles induced by Helicobacter suis infection. Pathog Dis. 2017; 75(1): ftx006. [CrossRef]
- [24] Vanhee LM, Goemé F, Nelis HJ, Coenye T. Quality control of fifteen probiotic products containing Saccharomyces boulardii. J Appl Microbiol. 2010; 109(5): 1745-1752. [CrossRef]
- [25] Mendes JJ, Leandro CI, Bonaparte DP, Pinto AL. A rat model of diabetic wound infection for the evaluation of topical antimicrobial therapies. Comp Med. 2012; 62(1): 37-48.
- [26] Nayak BS, Maiya A, Kumar P. Influence of Helium-Neon laser photostimulation on excision wound healing in Wistar rats. Online J Biol Sci. 2007; 7(2): 89-92. [CrossRef]
- [27] Murthy S, Gautam MK, Goel S, Purohit V, Sharma H, Goel RK. Evaluation of in vivo wound healing activity of Bacopa monniera on different wound model in rats. Biomed Res Int. 2013; 2013: 972028. [CrossRef]
- [28] Kirdak T, Uysal E, Sezgin E, Cecen GS, Cavun S. Inflammatory response markers in rats undergoing abdominal surgical procedures. Ann Gastroenterol. 2020; 33(5): 528-535. [CrossRef]
- [29] Parasuraman S, Raveendran R, Kesavan R. Blood sample collection in small laboratory animals. J Pharmacol Pharmacother. 2010; 1(2): 87. [CrossRef]
- [30] Jia HP, Mills JN, Barahmand-Pour F, Nishimura D, Mallampali RK, Wang G, Wiles K, Tack BF, Bevins CL, McCray Jr PB. Molecular cloning and characterization of rat genes encoding homologues of human β-defensins. Infect Immun. 1999 ;67(9): 4827-4833. [CrossRef]
- [31] Kurland AR, Schreiner H, Diamond G. In vivo β‐defensin gene expression in rat gingival epithelium in response to Actinobacillus actinomycetemcomitans infection. J Periodontal Res. 2006; 41(6): 567-572. [CrossRef]
- [32] Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018; 9: 754. [CrossRef]
- [33] Mazidi M, Rezaie P, Ferns GA, Vatanparast H. Impact of Probiotic Administration on Serum C-Reactive Protein Concentrations: Systematic Review and Meta-Analysis of Randomized Control Trials. Nutrients. 2017; 9(1): 20. [CrossRef]
- [34] Lukic J, Chen V, Strahinic I, Begovic J, Lev‐Tov H, Davis SC, Tomic‐Canic M, Pastar I. Probiotics or pro‐healers: the role of beneficial bacteria in tissue repair. Wound Repair Regen. 2017; 25(6): 912-922. [CrossRef]
- [35] Rodrigues KL, Caputo LR, Carvalho JC, Evangelista J, Schneedorf JM. Antimicrobial and healing activity of kefir and kefiran extract. Int J Antimicrob Agents. 2005; 25(5): 404-408. [CrossRef]
- [36] Tagliari E, Campos LF, Campos AC, Costa-Casagrande TA, Noronha LD. Effect of probiotic oral administration on skin wound healing in rats. ABCD. Arq Bras Cir Dig (São Paulo). 2019; 32. [CrossRef]
- [37] Jones M, Ganopolsky JG, Labbé A, Gilardino M, Wahl C, Martoni C, Prakash S. Novel nitric oxide producing probiotic wound healing patch: preparation and in vivo analysis in a New Zealand white rabbit model of ischaemic and infected wounds. Int Wound J. 2012; 9(3):330-343. [CrossRef]
- [38] Wu X, Vallance BA, Boyer L, Bergstrom KS, Walker J, Madsen K, O'Kusky JR, Buchan AM, Jacobson K. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am J Physiol Gastrointest Liver Physiol. 2008; 294(1): G295-306. [CrossRef]
- [39] Abiko Y, Saitoh M, Nishimura M, Yamazaki M, Sawamura D, Kaku T. Role of β-defensins in oral epithelial health and disease. Med Mol Morphol. 2007; 40(4): 179-184. [CrossRef]
Details
| Primary Language | English |
|---|---|
| Subjects | Clinical Pharmacy and Pharmacy Practice |
| Journal Section | Articles |
| Authors | |
| Publication Date | June 28, 2025 |
| Published in Issue | Year 2022 Volume: 26 Issue: 5 |